These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30561892)

  • 21. Performance of the automated and rapid STA Liatest D-dimer on the STA-R analyzer.
    Waser G; Kathriner S; Wuillemin WA
    Thromb Res; 2005; 116(2):165-70. PubMed ID: 15907532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 24. Importance of anticoagulant proteins in chronic liver diseases.
    Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
    Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods for correcting inhibitory effects of fibrinogen degradation products in fibrinogen determinations.
    Alving BM; Bell WR
    Thromb Res; 1976 Jul; 9(1):1-8. PubMed ID: 960061
    [No Abstract]   [Full Text] [Related]  

  • 26. INFLUENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) ON PLATELET AGGREGATION, ADHESIVENESS AND VISCOUS METAMORPHOSIS.
    KOWALSKI E; KOPEC M; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Jan; 10():406-23. PubMed ID: 14113380
    [No Abstract]   [Full Text] [Related]  

  • 27. Laboratory-monitored fondaparinux and coagulation activity in association with total hip replacement.
    Virtanen L; Salmela B; Leinonen J; Lemponen M; Huhtala J; Joutsi-Korhonen L; Lassila R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):597-603. PubMed ID: 24732174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
    Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
    Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen/fibrin degradation products (FDP/fdp). Characterization, anticoagulant activity, and influence on laboratory assays.
    Arnesen H
    J Oslo City Hosp; 1977 Jun; 27(6):69-80. PubMed ID: 142131
    [No Abstract]   [Full Text] [Related]  

  • 30. [Markers of hypercoagulability during pregnancy: thrombin-antithrombin-III complexes and D dimer].
    Senent M; Bellart J; Zuazu-Jausoro I; Oliver A; Montserrat I; Ribera L; Tirado I; Cabero L; Fontcuberta J
    Sangre (Barc); 1991 Feb; 36(1):21-4. PubMed ID: 1853270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
    Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
    J Med; 1984; 15(2):149-60. PubMed ID: 6096471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.
    Riva N; Vella K; Hickey K; Bertù L; Zammit D; Spiteri S; Kitchen S; Makris M; Ageno W; Gatt A
    J Clin Pathol; 2018 Nov; 71(11):1015-1022. PubMed ID: 30093507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of fibrin formation in exercise-induced activation of coagulation.
    Vogt A; Hofmann V; Straub PW
    Am J Physiol; 1979 Apr; 236(4):H577-9. PubMed ID: 434223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical implication of plasma level of soluble fibrin monomer-fibrinogen complex in patients with abdominal aortic aneurysm.
    Hosaka A; Miyata T; Aramoto H; Shigematsu H; Nakazawa T; Okamoto H; Shigematsu K; Nagawa H
    J Vasc Surg; 2005 Aug; 42(2):200-5. PubMed ID: 16102614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative studies of pharmacokinetics and anticoagulatory effect in rats after oral administration of Frankincense and its processed products.
    Pan YN; Liang XX; Niu LY; Wang YN; Tong X; Hua HM; Zheng J; Meng DY; Liu XQ
    J Ethnopharmacol; 2015 Aug; 172():118-23. PubMed ID: 26117531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-Dimer Testing: Laboratory Aspects and Current Issues.
    Thachil J; Lippi G; Favaloro EJ
    Methods Mol Biol; 2017; 1646():91-104. PubMed ID: 28804821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation Profile at Diagnosis in Patients with Acute Lymphoblastic Leukemia.
    Sehgal S; Sharma S; Chandra J; Nangia A
    Indian J Pediatr; 2016 Oct; 83(10):1082-6. PubMed ID: 27109393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock.
    Andersen MG; Hvas CL; Tønnesen E; Hvas AM
    Acta Anaesthesiol Scand; 2014 May; 58(5):525-33. PubMed ID: 24580049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
    Horan JT; Francis CW
    Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
    Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
    Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.